Twentyeight-Seven Therapeutics

Twentyeight-Seven Therapeutics

Latest funding
$15,000,000
Venture capital (Series A) - 2019
Sofinnova Partners Novartis Venture Fund MPM Capital +4
Team Size
1–10
Employees

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Twentyeight-Seven Therapeutics makes some noise.